Cargando…
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
BACKGROUND: Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown. METHODS: We identified a nationwide historic cohort of 19 146 women who received IVF treatment in the Netherlands between 1983 and 1995, and a comparison group of 6006 subfertile women not t...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212878/ https://www.ncbi.nlm.nih.gov/pubmed/22031719 http://dx.doi.org/10.1093/humrep/der322 |
_version_ | 1782216036774313984 |
---|---|
author | van Leeuwen, F.E. Klip, H. Mooij, T.M. van de Swaluw, A.M.G. Lambalk, C.B. Kortman, M. Laven, J.S.E. Jansen, C.A.M. Helmerhorst, F.M. Cohlen, B.J. Willemsen, W.N.P. Smeenk, J.M.J. Simons, A.H.M. van der Veen, F. Evers, J.L.H. van Dop, P.A. Macklon, N.S. Burger, C.W. |
author_facet | van Leeuwen, F.E. Klip, H. Mooij, T.M. van de Swaluw, A.M.G. Lambalk, C.B. Kortman, M. Laven, J.S.E. Jansen, C.A.M. Helmerhorst, F.M. Cohlen, B.J. Willemsen, W.N.P. Smeenk, J.M.J. Simons, A.H.M. van der Veen, F. Evers, J.L.H. van Dop, P.A. Macklon, N.S. Burger, C.W. |
author_sort | van Leeuwen, F.E. |
collection | PubMed |
description | BACKGROUND: Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown. METHODS: We identified a nationwide historic cohort of 19 146 women who received IVF treatment in the Netherlands between 1983 and 1995, and a comparison group of 6006 subfertile women not treated with IVF. In 1997–1999, data on reproductive risk factors were obtained from 65% of women and data on subfertility (treatment) were obtained from the medical records. The incidence of ovarian malignancies (including borderline ovarian tumours) through 2007 was assessed through linkage with disease registries. The risk of ovarian malignancies in the IVF group was compared with risks in the general population and the subfertile comparison group. RESULTS: After a median follow-up of 14.7 years, the risk of borderline ovarian tumours was increased in the IVF group compared with the general population [standardized incidence ratio (SIR) = 1.76; 95% confidence interval (CI) = 1.16–2.56]. The overall SIR for invasive ovarian cancer was not significantly elevated, but increased with longer follow-up after first IVF (P = 0.02); the SIR was 3.54 (95% CI = 1.62–6.72) after 15 years. The risks of borderline ovarian tumours and of all ovarian malignancies combined in the IVF group were significantly increased compared with risks in the subfertile comparison group (hazard ratios = 4.23; 95% CI = 1.25–14.33 and 2.14; 95% CI = 1.07–4.25, respectively, adjusted for age, parity and subfertility cause). CONCLUSIONS: Ovarian stimulation for IVF may increase the risk of ovarian malignancies, especially borderline ovarian tumours. More large cohort studies are needed to confirm these findings and to examine the effect of IVF treatment characteristics. |
format | Online Article Text |
id | pubmed-3212878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32128782011-11-10 Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort van Leeuwen, F.E. Klip, H. Mooij, T.M. van de Swaluw, A.M.G. Lambalk, C.B. Kortman, M. Laven, J.S.E. Jansen, C.A.M. Helmerhorst, F.M. Cohlen, B.J. Willemsen, W.N.P. Smeenk, J.M.J. Simons, A.H.M. van der Veen, F. Evers, J.L.H. van Dop, P.A. Macklon, N.S. Burger, C.W. Hum Reprod Original Articles BACKGROUND: Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown. METHODS: We identified a nationwide historic cohort of 19 146 women who received IVF treatment in the Netherlands between 1983 and 1995, and a comparison group of 6006 subfertile women not treated with IVF. In 1997–1999, data on reproductive risk factors were obtained from 65% of women and data on subfertility (treatment) were obtained from the medical records. The incidence of ovarian malignancies (including borderline ovarian tumours) through 2007 was assessed through linkage with disease registries. The risk of ovarian malignancies in the IVF group was compared with risks in the general population and the subfertile comparison group. RESULTS: After a median follow-up of 14.7 years, the risk of borderline ovarian tumours was increased in the IVF group compared with the general population [standardized incidence ratio (SIR) = 1.76; 95% confidence interval (CI) = 1.16–2.56]. The overall SIR for invasive ovarian cancer was not significantly elevated, but increased with longer follow-up after first IVF (P = 0.02); the SIR was 3.54 (95% CI = 1.62–6.72) after 15 years. The risks of borderline ovarian tumours and of all ovarian malignancies combined in the IVF group were significantly increased compared with risks in the subfertile comparison group (hazard ratios = 4.23; 95% CI = 1.25–14.33 and 2.14; 95% CI = 1.07–4.25, respectively, adjusted for age, parity and subfertility cause). CONCLUSIONS: Ovarian stimulation for IVF may increase the risk of ovarian malignancies, especially borderline ovarian tumours. More large cohort studies are needed to confirm these findings and to examine the effect of IVF treatment characteristics. Oxford University Press 2011-12 2011-10-26 /pmc/articles/PMC3212878/ /pubmed/22031719 http://dx.doi.org/10.1093/humrep/der322 Text en © The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited |
spellingShingle | Original Articles van Leeuwen, F.E. Klip, H. Mooij, T.M. van de Swaluw, A.M.G. Lambalk, C.B. Kortman, M. Laven, J.S.E. Jansen, C.A.M. Helmerhorst, F.M. Cohlen, B.J. Willemsen, W.N.P. Smeenk, J.M.J. Simons, A.H.M. van der Veen, F. Evers, J.L.H. van Dop, P.A. Macklon, N.S. Burger, C.W. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
title | Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
title_full | Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
title_fullStr | Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
title_full_unstemmed | Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
title_short | Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort |
title_sort | risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large dutch cohort |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212878/ https://www.ncbi.nlm.nih.gov/pubmed/22031719 http://dx.doi.org/10.1093/humrep/der322 |
work_keys_str_mv | AT vanleeuwenfe riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT kliph riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT mooijtm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT vandeswaluwamg riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT lambalkcb riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT kortmanm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT lavenjse riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT jansencam riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT helmerhorstfm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT cohlenbj riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT willemsenwnp riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT smeenkjmj riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT simonsahm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT vanderveenf riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT eversjlh riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT vandoppa riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT macklonns riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort AT burgercw riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort |